Interested in earning 4.0 ACCME, ACPE, AANP, ANCC or APA credit hours?
When purchasing your conference pass to attend the "Medical Cannabis Patient Therapies & Wellness Summit” receive our TheAnswerPage.com partner discount to their Marij-thon: Comprehensive Medical Marijuana Course, course from $299 to $199! The course and curriculum fulfills the Massachusetts Cannabis Control Commission’s education requirement for certifying patients for medical marijuana.
Like many other states, Massachusetts clinicians are required to take a certain number of continuing medical education credits in order to recommend cannabis to patients, it is imperative that physicians be prepared to answer questions about marijuana use and to counsel their patients about any potential impact cannabis may have. Many states have legalized medical cannabis which is why it’s even more important that doctors, nurses and pharmacists are educated in order to better communicate with each other when taking care of patients.
The Marij-thon: Comprehensive Medical Marijuana Course provides a total of 4.0 ACCME, ACPE, AANP, ANCC or APA credit hours. Subscribers can complete this course and refer back to the content at any point during their 12-month subscription period.
The CME/CE activity includes the following courses:
1. The Comprehensive Medical Marijuana Curriculum introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions. The use of cannabinoid-based medicines in obstetric, pediatric, adolescent and elderly patients is addressed in detail. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided.
2. Health Effects of Marijuana and Cannabinoids in Epilepsy describes how the endocannabinoid system may affect seizure threshold, and reviews the available research and clinical evidence for the use of cannabinoids in the treatment of epilepsy. In addition, there is a discussion about an FDA-approved cannabis-based medicine for the treatment of severe forms of epilepsy.
3. Legal and Medical Considerations in the Recommendation of Medical Marijuana provides a thorough review of the considerations associated with the recommendation of medical marijuana, and information on the prescribing of FDA-approved cannabinoid-based medicines.
Please contact us for detailed information.